Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1101 | 1102 | (Page 1103) | 1104 | 1105 | .... | 1118 | newer

    0 0

    (EMAILWIRE.COM, November 28, 2018 ) “Global Breast Imaging Market 2018” report provides information on grasping newer technologies and recent development made in Breast Imaging & satisfies specialized and enterprise-wide statistical needs.

    This report studies the global market size of Breast Imaging in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Breast Imaging in these regions.
    This research report categorizes the global Breast Imaging market by top players/brands, region, type and end user. This report also studies the global Breast Imaging market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

    Download Free PDF Sample of Global Breast Imaging Market 2018 report @ https://decisionmarketreports.com/request-sample?productID=858498

    Breast Imaging is an equipment to examine the women’s breast, and it is used as a diagnostic and screening tool. Breast Imaging Equipment is for the early detection of breast cancer, typically through characteristic masses’ detection. In the last several years, China market of Breast Imaging Equipment developed rapidly, with an average growth rate of 6%. In 2015, China capacity of Breast Imaging Equipment is nearly 450 units, and the actual production is about 360 units.

    South China is the largest production province of Breast Imaging Equipment, with production market share nearly 42%. And its sales market share of Breast Imaging Equipment is 18%. Main manufacturers of Breast Imaging Equipment in South China are ANKE, Angell, Sinomdt, Macroo, etc.

    The second largest production province is North China, following South China with the production market share of 32% and the sales market share nearly 23%. The manufacturing factory of Hologic is located in Beijing. There are lots of products exported to other regions from North China every year.

    Players with high-quality products are Philips, Siemens, Hologic, GE Healthcare, etc. But only Philips, Siemens, Hologic have plants in China, which is very helpful for promoting their position in Chinese Breast Imaging Equipment market.

    For foreign manufacturers, it would be better to set local plants or to cooperate with local manufacturers.

    Breast Imaging Equipment Industry is relatively young in China, and the potential market is very attractive. So investment for Breast Imaging Equipment is promising.

    The global Breast Imaging market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The objectives of this study are to define, segment, and project the size of the Breast Imaging market based on company, product type, end user and key regions.

    The following manufacturers are covered in this report, with sales, revenue, market share for each company:
    Siemens
    Philips
    Hologic
    Perlong Medical
    ANKE
    Angell
    Sinomdt
    Macroo
    Orich Medical Equipment
    GE Healthcare
    Planmed
    Metaltronica
    TOSHIBA
    MEDI-FUTURE
    FUJIFILM
    IMS
    Genoray

    Market size by Product
    Analog Breast Imaging Equipment
    Digital Breast Imaging Equipment
    Market size by End User
    General Surgery
    Breast Surgery
    Physical examination

    Access full report with TOC @ https://decisionmarketreports.com/market-reports/858498/global-breast-imaging-market

    Market size by Region
    North America
    United States
    Canada
    Mexico
    Asia-Pacific
    China
    India
    Japan
    South Korea
    Australia
    Indonesia
    Singapore
    Malaysia
    Philippines
    Thailand
    Vietnam
    Europe
    Germany
    France
    UK
    Italy
    Spain
    Russia
    Central & South America
    Brazil
    Rest of Central & South America
    Middle East & Africa
    GCC Countries
    Turkey
    Egypt
    South Africa

    Table of Contents

    1 Study Coverage
    1.1 Breast Imaging Product
    1.2 Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
    1.4.1 Global Breast Imaging Market Size Growth Rate by Product
    1.4.2 Analog Breast Imaging Equipment
    1.4.3 Digital Breast Imaging Equipment
    1.5 Market by End User
    1.5.1 Global Breast Imaging Market Size Growth Rate by End User
    1.5.2 General Surgery
    1.5.3 Breast Surgery
    1.5.4 Physical examination
    1.6 Study Objectives
    1.7 Years Considered

    2 Executive Summary
    2.1 Global Breast Imaging Market Size
    2.1.1 Global Breast Imaging Revenue 2013-2025
    2.1.2 Global Breast Imaging Sales 2013-2025
    2.2 Breast Imaging Growth Rate by Regions
    2.2.1 Global Breast Imaging Sales by Regions
    2.2.2 Global Breast Imaging Revenue by Regions

    3 Breakdown Data by Manufacturers
    3.1 Breast Imaging Sales by Manufacturers
    3.1.1 Breast Imaging Sales by Manufacturers
    3.1.2 Breast Imaging Sales Market Share by Manufacturers
    3.1.3 Global Breast Imaging Market Concentration Ratio (CR5 and HHI)
    3.2 Breast Imaging Revenue by Manufacturers
    3.2.1 Breast Imaging Revenue by Manufacturers (2013-2018)
    3.2.2 Breast Imaging Revenue Share by Manufacturers (2013-2018)
    3.3 Breast Imaging Price by Manufacturers
    3.4 Breast Imaging Manufacturing Base Distribution, Product Types
    3.4.1 Breast Imaging Manufacturers Manufacturing Base Distribution, Headquarters
    3.4.2 Manufacturers Breast Imaging Product Type
    3.4.3 Date of International Manufacturers Enter into Breast Imaging Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product
    4.1 Global Breast Imaging Sales by Product
    4.2 Global Breast Imaging Revenue by Product
    4.3 Breast Imaging Price by Product

    Continued...

    About Decision Market Reports
    Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

    Contact Information:
    Gasper James,
    Decision Market Reports,
    304 S Jones Blvd,
    Las Vegas,
    NV 89107, USA
    Call: 1-800-526-8630 (Toll-Free)
    Email:sales@decisionmarketreports.com




    Gasper James
    +1-866-605-1052
    g.james @decisionmarketreports.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 28, 2018 ) Vaginal rejuvenation is the procedure that comprises vaginal construction or reconstruction through invasive or non-invasive surgeries. According to the American Society for Aesthetic Plastic Surgery, vaginal rejuvenation is highly popular and is the latest cosmetic trend in the cosmetic and beauty market. The demand for vaginal rejuvenation is high. Nowadays, beauty is very important for women and the desire for beauty enhancement is not limited to the face anymore. The vaginal rejuvenation procedure mainly focuses on the improvement of the cosmetic appearance and tightening of the vagina to enhance sexual function. The currently available treatment options for vaginal rejuvenation are reconstructive vaginal rejuvenation, functional vaginal rejuvenation and cosmetic vaginal rejuvenation. Reconstructive vaginal rejuvenation surgeries are aimed at correcting and repairing the anatomical structure of a vagina. In these procedures, surgeons decrease the diameter of the vagina and correct the incontinence, pelvic organ prolapse and congenitally malformed vagina. They also repair defects caused after vaginal delivery. Functional vaginal rejuvenation mainly focuses on the enhancement of sexual sensations. This is done by increasing clitoral stimulation for better sexual pleasure and the amplification of the G-spot by injecting collagen to make it more sensitive and large.

    Cosmetic vaginal rejuvenations procedures are aimed at altering the appearance of the vulva and vaginal opening. These procedures include labioplasty, in which the inner labia is reduced and the unwanted fat from the mons pubis & the upper part of the labia majora is removed. In addition, the revirginisation procedure is carried out to repair the hymen and hoodectomy is performed to reduce the clitoral cover.

    However, vaginal rejuvenation surgical procedures carry the risk of complications such as scarring, infections, impaired blood supply and the impairing of the nerve, which is likely to result in painful sexual intercourse or decrease sexual sensation. Vaginal rejuvenation is performed by gynaecologists or plastic surgeons to reduce the vaginal average diameter, mainly for sexual reasons.

    Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1767 

    Vaginal Rejuvenation Market: Drivers and Restraints

    Revolutionary developments in the cosmetic and beauty industry increase the desire for body enhancement in women. The increasing popularity of vaginal rejuvenation is gaining attention worldwide. Usually, vaginal rejuvenation is recommended to women whose vagina has widened due to vaginal delivery or aging. Women think that vaginal rejuvenation will increase their self-confidence and comfort. Progressively, vaginal rejuvenation has become a common option for women. The above-mentioned factors are boosting the demand for vaginal rejuvenation procedures. However, some of the developing countries are unaware of these technologies and, in certain countries, body enhancement considered a taboo. Moreover, vaginal rejuvenation treatments are very costly. These factors are likely to hamper the growth of the vaginal rejuvenation market.

    Vaginal Rejuvenation Market: Segmentation

    The global Vaginal Rejuvenation Market can be segmented on the basis of treatment type, end user and geography.

    Based on treatment type, the global vaginal rejuvenation market is segmented as:

    Reconstructive vaginal rejuvenation
    Perineoplasty
    Vaginoplasty
    Functional vaginal rejuvenation
    Clitorial Unhooding
    G-Spot amplification
    Cosmetic vaginal rejuvenation
    Labioplasty
    Revirginization
    Hoodectomy
    Based on end user, the global vaginal rejuvenation market is segmented as:

    Hospitals
    Clinics
    Others
    Based on geography, the global vaginal rejuvenation market is segmented as:

    North America
    Latin America
    Europe
    Asia-Pacific excluding Japan (APEJ)
    Japan
    Middle East & Africa (MEA)
    Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1767 

    Vaginal Rejuvenation Market: Overview

    The global market for vaginal rejuvenation is expected to register growth over the forecast period. The increasing popularity of vaginal rejuvenation and the commercialisation & marketing of vaginal procedures are among factors likely to boost the market. In the recent years, vaginal rejuvenation has gained a lot of attention and popularity among healthcare providers and women. Vaginal rejuvenation is considered an effective and safe surgical procedure for enhancing the sexual function in women with minimal vaginal sensation, which results in sexual disappointment. Several technological advancements have been introduced in this field. Before, invasive procedures performed for vaginal tightening were painful and had adverse effects, however, in the recent years, non-invasive procedures have been introduced to overcome these adverse effects and give the desired results. Recently, there has been an increase in innovative and non-invasive procedures as opposed to traditional surgical techniques, which indicate that these techniques are the safest and most effective with few or no complications caused after surgery. However, the major concern is that there is poor scientific confirmation of the efficiency of vaginal rejuvenation procedures.

    Vaginal Rejuvenation Market: Regional Outlook

    Geographically, the global vaginal rejuvenation market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East & Africa (MEA). North America is expected to be a dominant market in the global vaginal rejuvenation market, followed by Europe, due to the growth of the cosmetic and beauty market. Moreover, the rising popularity of vaginal rejuvenation and the introduction of new innovative non-invasive procedures over traditional invasive surgeries is also boosting the market. The American Society of Plastic Surgeons reported a 30% increase in the number of vaginal rejuvenation procedures in the U.S. However, the vaginal rejuvenation market in Asia Pacific excluding Japan and the Middle East & Africa (MEA) is expected to grow at a steady growth rate as there is low awareness about vaginal rejuvenation procedures and body enhancement is limited to the face and few other body parts. In addition, the cost of these procedures is high, which limits the growth of the vaginal rejuvenation market in these regions.

    Vaginal Rejuvenation Market: Key Players

    Some of the key players in the global vaginal rejuvenation market are Almirall, Viveve Medical, Fotona and Hologic.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies involved
    Technology
    Value Chain
    Regional analysis includes

    North America (U.S., Canada)
    Latin America (Mexico, Brazil)
    Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
    Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
    Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
    Japan
    Middle East and Africa (GCC, S. Africa, Rest Of MEA)
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint.

    Report Analysis@ https://www.factmr.com/report/1767/vaginal-rejuvenation-market 


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 28, 2018 ) Veterinary Radiography Flat Panel Detectors Market: Introduction

    When it comes to the diagnosis, treatment and detection of diseases of pets and animals, they deserve the best treatment. Companion animals, pets and agricultural livestock are presently receiving benefits from the same flat panel technology that is used in X-ray systems for human patients. Veterinary radiography flat panel detectors effectively image the small structure of animals with high resolution and good image quality. Advancements in veterinary radiography flat panel detectors result in perfect digital images irrespective of declination or inclination. Veterinary radiography flat panel detectors are lightweight, durable and offer wireless flat panel detectors designed for digital radiographic imaging, keeping the ambulatory veterinarian in mind. Veterinary radiography flat panel detectors are also equipped with the Wi-Fi direct technology, which allows the veterinary radiography flat panel detectors to connect with the acquisition device without the need for an access point. Veterinary radiography flat panel detectors use a revolutionary technology that captures the radiographic images in digital format within a second and eliminates the need for phosphorescent screens, X-ray films and cassettes.

    Veterinary Radiography Flat Panel Detectors Market: Drivers and Restraints

    Rising demand for medical imaging for companion animals, pets and agricultural livestock for better diagnosis and treatment monitoring is a major factor expected to drive the global veterinary radiography flat panel detectors market. Over the past few years, it has been observed that technological developments in the veterinary industry are boosting the demand for veterinary radiography flat panel detectors along with veterinary technicians across the globe. This consequently increases the demand for trained veterinary professionals, which, in turn, increases the trust of pet owners & drives the veterinary radiography flat panel detectors market. Furthermore, affordability and accessibility of theses product contribute to the growth of the global veterinary radiography flat panel detectors market. However, new drug inventions and influence towards alternative treatment options are likely hamper the growth of the global veterinary radiography flat panel detectors market.

    Click here to subscribe Sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1766 

    Veterinary Radiography Flat Panel Detectors Market: Segmentation

    The global veterinary radiography flat panel detectors market can be segmented on the basis of product type, panel size end user and geography.

    Based on product type, the global veterinary radiography flat panel detectors market is segmented as:

    Direct veterinary radiography flat panel detectors
    Indirect veterinary radiography flat panel detectors
    Based on panel size, the global veterinary radiography flat panel detectors market is segmented as:

    Large-area veterinary radiography flat panel detectors
    Small-area veterinary radiography flat panel detectors
    Based on end user, the global veterinary radiography flat panel detectors market is segmented as:

    Veterinary Hospitals
    Veterinary Clinics
    Others
    Veterinary Radiography Flat Panel Detectors Market: Overview

    The global market for veterinary radiography flat panel detectors is expected to witness a significant growth rate over the forecast period.  Based on the product type, the global veterinary radiography flat panel detectors market is segmented into direct and indirect veterinary radiography flat panel detectors. Direct veterinary radiography flat panel detectors directly convert the X-ray photons into electric charge, whereas indirect veterinary radiography flat panel detectors first convert X-rays into visible light and then to electrical charges. Based on panel size, the global veterinary radiography flat panel detectors market is segmented into the large-area and small-area veterinary radiography flat panel detectors. Based on the end user, the veterinary radiography flat panel detectors market is segmented into veterinary hospitals, veterinary clinics and others. The veterinary hospitals end-user segment is projected to contribute a maximum share to the veterinary radiography flat panel detectors market. The veterinary hospitals segment is considered the most accessible end-user segment among others.

    Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=1766 

    Veterinary Radiography Flat Panel Detectors Market: Regional Outlook

    Geographically, the global veterinary radiography flat panel detectors market is segmented into North America, Latin America, Europe, CIS & Russia, Asia Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). The North America veterinary radiography flat panel detectors market is expected to register a maximum market share in the global veterinary radiography flat panel detectors market, followed by Europe, due to the rising adoption rate of advanced medical imaging techniques for animals. In addition, increase in pet adoption and the rising demand for pet health insurance are also fuelling the market for veterinary radiography flat panel detectors. For instance, the United States Animal Health Association (USAHA) is a non-profit voluntary organisation that works with federal and state governments to control livestock diseases in the U.S. According to the American Society for the Prevention of Cruelty to Animals, every year, around 3.2 million shelter animals are adopted. However, the Asia Pacific region represents the fastest-growing market for veterinary radiography flat panel detectors. Asia Pacific is expected to grow with a maximum CAGR and is projected to be a lucrative market for new emerging players in the veterinary radiography flat panel detectors market. This is primarily due to the rising adoption of pets and the growing population of livestock. However, Latin America and the Middle East & Africa regions are expected to register considerably slow growth over the forecast period.    

    Veterinary Radiography Flat Panel Detectors Market: Key Players

    Some of the key players operating in the global veterinary radiography flat panel detectors market are, OR Technology, Varex Imaging Corporation, FUJIFILM Corporation, Diagnostic Imaging Systems, Vieworks Co., Ltd. and MyVet Imaging. Majority of players operating in the global veterinary radiography flat panel detectors market are aiming for geographical expansion by adopting new strategies, such as collaborations, mergers, acquisitions, agreements and others, to strengthen their presence in the global veterinary radiography flat panel detectors market.

    The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.

    The report covers exhaustive analysis on:

    Market Segments
    Market Dynamics
    Market Size
    Supply & Demand
    Current Trends/Issues/Challenges
    Competition & Companies Involved
    Technology
    Value Chain
    Regional analysis includes:

    North America (U.S., Canada)
    Latin America (Mexico, Brazil, Argentina, Peru, Chile, Rest of LATAM)
    Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX, Eastern Europe, Rest of Europe)
    CIS & Russia
    Japan
    Asia Pacific Excluding Japan ( Greater China, India, South Korea, ASEAN Countries, Rest of APEJ)
    Middle East and Africa (GCC Countries, Turkey, Iran, Israel, S. Africa, Rest of MEA)
    Report Highlights:

    Detailed overview of parent market
    Changing market dynamics in the industry
    In-depth market segmentation
    Historical, current and projected market size in terms of volume and value
    Recent industry trends and developments
    Competitive landscape
    Strategies of key players and products offered
    Potential and niche segments, geographical regions exhibiting promising growth
    A neutral perspective on market performance
    Must-have information for market players to sustain and enhance their market footprint

    Report Analysis@ https://www.factmr.com/report/1766/veterinary-radiography-flat-panel-detectors-market 


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 29, 2018 ) According to research report "Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    Browse 70 market data tables and 42 figures spread through 126 pages and in-depth TOC on "Blood Flow Measurement Devices Market - Global Forecast to 2021"
    https://www.marketsandmarkets.com/Market-Reports/blood-flow-measurement-devices-market-243081818.html

    This report studies the global Blood Flow Measurement Devices Market for the forecast period of 2016 to 2021. This market is expected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2%.

    The global blood flow measurement devices market is segmented on the basis of product, application, and region.

    Based on product, the blood flow measurement devices market is categorized into ultrasound and laser Doppler. In 2016, the ultrasound segment commanded the largest share of the global blood flow measurement device market. This growth can be attributed to the growing applications of ultrasound products, such as vascular diseases and dermatology, and their usability in invasive as well as non-invasive applications. The ultrasound market is further categorized into ultrasound Doppler and transit-time flow meters (TTFM). In 2016, the ultrasound Doppler segment commanded the largest share of the global ultrasound market. The large share and high growth rate of these devices can be attributed to their growing applications, ease of use, and increased preference for non-invasive devices.

    Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=243081818

    Based on application, the blood flow measurement devices market is segmented into non-invasive applications and invasive applications. Non-invasive applications are further categorized into cardiovascular disease, diabetes, tumor monitoring, gastroenterology, and others applications (dermatology and intracranial pressure monitoring). The cardiovascular disease segment commanded the largest share of the global blood flow measurement device market, by non-invasive applications, in 2016. The large share and high growth rate of this segment can be attributed to the increasing prevalence of cardiovascular disease, rising geriatric population, and increasing focus of key market players on this market. Similarly, invasive applications are further segmented into coronary arterial bypass graft (CABG), microvascular surgery, and others (organ transplants and reconstructive surgery). The CABG segment commanded the largest share of the global blood flow measurement devices market in 2016. The growth in this segment can be attributed to a large number of CABG surgeries performed worldwide.

    Sample of the report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=243081818

    The key players in the blood flow measurement devices market include Cook Medical, Inc. (U.S.), Medistim ASA (Norway), Transonic Systems, Inc. (U.S.), ADInstruments (Australia), Moor Instruments Ltd. (U.K.), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), Compumedics Ltd. (Australia), Perimed AB (Sweden), and SONOTEC Ultraschallsensorik Halle GmbH (Germany).



    Contact:
    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA : 1-888-600-6441
    newsletter@marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 29, 2018 ) According to research report "Perfusion Systems Market (Cardiopulmonary Perfusion, by Component (Heart-lung Machines, Oxygenators), Ex Vivo Organ Perfusion, Technique (Hypothermic, Normothermic), Cell Perfusion, by Type (Bioreactor, Microfluidic)) - Global Forecast to 2021", The global perfusion systems market is expected to reach USD 1,198.8 Million by 2021 from USD 989.4 Million in 2016, at a CAGR of 3.9%.

    Browse 74 market data tables and 61 figures spread through 152 pages and in-depth TOC on "Perfusion Systems Market - Global Forecast to 2021"https://www.marketsandmarkets.com/Market-Reports/perfusion-system-market-164273069.html

    The growth of the market can be attributed to the increasing prevalence of cardiovascular & respiratory diseases, initiatives by governments & NGOs to encourage organ donation, increasing investment in cell-based research, and developments in biologics manufacturing. The high cost of organ transplantation and organ supply-demand gap, however, are expected to hinder the growth of the market.

    The perfusion systems market is segmented on the basis of type (namely cardiopulmonary perfusion systems, ex vivo organ perfusion systems, and cell perfusion systems) and region. By component, the cardiopulmonary perfusion systems market is segmented into heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas, and other components. The oxygenators segment accounted for the largest share of the cardiopulmonary perfusion systems market in 2016.

    Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164273069

    Based on technique, the ex vivo organ perfusion systems market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment held the largest share of the ex vivo organ perfusion systems market in 2016 and is also projected to grow at the highest CAGR during the forecast period.

    The global cell perfusion systems market is segmented based on the type, as bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure-driven perfusion systems, and small-mammal organ perfusion systems. The bioreactor perfusion systems segment held the largest share of the cell perfusion systems market in 2016 and is projected to register the highest CAGR during the forecast period.

    Geographically, North America is estimated to account for the largest share of the global market, followed by Europe. The Asia-Pacific region is expected to witness the highest growth in the market during the forecast period. This growth will be particularly centered on China, Japan, and India.

    Sample of the report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=164273069;

    The major players in the cardiopulmonary perfusion systems market include Getinge AB (Sweden), Medtronic plc (Ireland), LivaNova PLC (U.K.), Terumo Corporation (Japan), and XENIOS AG (Germany). The major players in the ex vivo organ perfusion system market are Lifeline Scientific, Inc. (U.S.) and XVIVO Perfusion AB (Sweden), while, Repligen Corporation (U.S.), Spectrum Laboratories, Inc. (U.S.), Merck KGaA (Germany), Harvard Bioscience, Inc. (U.S.), and ALA Scientific Instruments, Inc. (U.S.) are some of the leading players in the cell perfusion systems market.




    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Research provides an in-depth analysis of the global Biotechnology Market with the current trends and future estimations to elucidate the imminent investment pockets.

    Biotechnology market is aimed to describe, define and estimate the forecast for market size of the biotechnology till 2025. The report strategically analyzes macro and micro-markets to entail the major factors impacting the growth of the global biotechnology market. The market report for biotechnology is appropriate to cater the needs and demands of various stakeholders that include pharmaceutical, biotechnology and medical companies in the form of research services.

    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100001316?nb

    North America is expected to be the dominant region in the global biotechnology market. This dominance is primarily driven by rising demand for innovative products from biopharmaceutical and biotechnology companies, significant presence of key market players and extensive R&D activities conducted by various academic and research institutes in the region. Additionally, increasing focus on advanced method incorporation in healthcare, growing government and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research is also expected to propel the growth for the North America market. On the other hand, Asia Pacific is expected to witness significant growth in the biotechnology market owing to factors such as availability of highly skilled, efficient & large number of human resources, and streamlining government policies resulting in high investments for biotechnology sector in the region.

    The major players operating in the biotechnology market include Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher, QIAGEN, BD, Bio-Rad Laboratories, Inc., Illumina, Inc. and among others. The global biotechnology market is highly competitive and driven by large number of novel product launches and approvals. For instance, in April 2017, Illumina, Inc. introduced BaseSpace Informatics Suite, used to accelerate genomic data analysis for sequence lab.

    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001316?nb

    The global biotechnology market estimated to grow at a CAGR of 10.5% during the forecast period from 2018 to 2025. The market for biotechnology was valued at USD 218,012.1 Mn in 2017 and is estimated to reach US$ 471,336.4 Mn by 2025.

    The global biotechnology market is segmented on the basis of technology and application and geography. On the basis of technology, the biotechnology market is segmented into DNA sequencing, fermentation, cell based assay, nanobiotechnology, chromatography, PCR technology, tissue engineering and regeneration and others. On the basis of application, the biotechnology market is segmented into industrial/bio processing, bioinformatics, food & agriculture, health, natural resource & environment and others.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Next Generation Sequencing Market Trends Opportunity Assessment, Market Challenges, Key vendor analysis, Vendor landscape by 2025.

    Demand for next generation sequencing technology has been increasing widely due to the rise in genetic tests. The availability of next generation sequencing at low cost, technological advancements and high prevalence of cancer cases during the previous years. Also, the companies operating the next generation sequencing market have been investing substantial time and amount in research and development activities, through which better technologies can be introduced in the market.

    Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery.

    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100000820?nb

    The next generation sequencing market is witnessing a healthy growth rate during the previous years and is expected to witness similar trend in the coming years. The companies operating in the market of next generation sequencing provide their products and services for applications such as drug discovery, diagnosis, and precision medicine.

    With constant R&D activities, the companies have been focusing towards developing advanced techniques in next generation sequencing that can be useful for end users such as hospitals & clinics, academic institutions, etc. Various players have been upgrading their product portfolio by applying for approvals. With expansion activities, companies are focusing towards strengthening their customer base by providing services to varied applications.
    ?
    The next generation sequencing market is well established in North America region, especially in the U.S and Canada. Companies are engaging in expansion activities in order to strengthen their customer presence in the region of North America, For instance, Illumina, Inc. and Telegraph together launched a new company, Verogen, which would provide Illumina’s forensic sequencing technology to forensic customers in the US. Advancements in technologies and declining prices are considered to be the driving factors in the next generation sequencing market.

    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100000820?nb

    The major players operating in the market of next generation sequencing market include F. Hoffmann-La Roche AG, PerkinElmer, Inc., Oxford Nanopore Technologies, Ltd., Eurofins Scientific, Thermo Fisher Scientific, Beijing Genomics Institute, Agilent Technologies, Qiagen N.V., Macrogen, Inc., and Illumina, Inc. among others


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Gene Therapy Market revenue generated by leading players has been determined through primary and secondary research 2019 - 2025.

    Gene therapy market is segmented based on type as, somatic gene therapy and germline gene therapy. The application segment is classified as genetic disorder, cancer, neurological disorder and others. The cancer segment is expected to grow in coming years as the need of gene correction is must as the gene corrector is introduced to produce a another gene or to inhibit the expression of another gene or to disturb the activity of another gene.

    Growth of the gene therapy market is regulated due to various reason which includes the rapid involvement of synthetically modified gene to treat various diseases, it helps in designing the personalized medicine, rise in the research and development of the gene therapy among the others. The gene therapy requires less doses of medicines and is one time treatment, this factor is likely to show growth opportunity for gene therapy market in coming near future.

    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100001165?nb

    Gene therapy is introduction of DNA into a patient to treat a genetic disease or a disorder. The newly inserted DNA contains a correcting gene to correct the effects of disease causing mutations. Gene therapy is promising treatment for the genetic diseases and also includes cystic fibrosis and muscular dystrophy. Gene therapy is suitable treatment for the infectious diseases, inherited disease and cancer.

    The gene therapy market is segmented based on type as, somatic gene therapy and germline gene therapy. The application segment is classified as genetic disorder, cancer, neurological disorder and others. The cancer segment is expected to grow in coming years as the need of gene correction is must as the gene corrector is introduced to produce a another gene or to inhibit the expression of another gene or to disturb the activity of another gene.

    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001165?nb

    The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global gene therapy market based on cell type, and application. It also provides market size and forecast till 2025 for overall gene therapy market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.

    North America is anticipated to dominate the gene therapy market in the global scenario owing to various factors such as reimbursement services, technological developments in the biotechnology industry and increasing research activities. Europe is the second largest market for the gene therapy as the various innovation are being done in this region. In 2016, European Union approved Zalmoxis for the treatment of leukemia. Asia Pacific is the fastest growing region as the studies are taking rapid pace for the biotechnological industry and increase in cardiovascular disease.. Owing to these factors the market are likely to propel the growth of the market for gene therapy market in coming future.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Bioreactors Market revenue generated by leading players has been determined through primary and secondary research 2019 - 2025.

    The “Global eHealth Market Analysis to 2025” is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global eHealth market with detailed market segmentation by product & services, end user and geography. The global eHealth market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.


    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100001210?nb


    The growth of the market can be attributed to increasing government initiatives supporting the use of eHealth solutions & services to deliver the higher care at low costs. Moreover, high prevalence of chronic diseases and growing need to manage regulatory compliance through the use of eHealth solutions are the factors that add new opportunities for the global eHealth market over the forecast period.

    The eHealth is used as an information and communication technology (ICT) for the development of healthcare infrastructure. These systems enables the healthcare facilities to offer personalized medicine, mobile health delivery, and social media e-health to their patients. Based on innovative technology these eHealth systems prioritize the delivery of clinical information, care & services.

    On the basis of product & services the market is segmented into eHealth solutions and eHealth services. The eHealth solutions segment is further segmented as cardiovascular information systems, e-prescribing solutions, radiology information systems, healthcare information exchange, telehealth solutions, clinical decision support systems, chronic care management apps, personal health record & patient portals, laboratory information systems, laboratory information systems, medical apps, pharmacy information systems, PACS & VNAS, electronic health records/electronic medical records solutions and other specialty information management systems. The eHealth services market is also further segmented into healthcare system strengthening services, treatment services, diagnosis & consultation services and remote monitoring services. Based on end user the eHealth market classified as healthcare providers, healthcare payers, and other end users.

    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001210?nb


    North America followed by Europe, is expected to dominate the eHealth market in the global arena due to the well-established healthcare infrastructure, and rising number of initiatives from the American Health Information Community (AHIC) in the region. Asia-Pacific region is anticipated to show a significant growth rate over the next five years in the global eHealth market due to the increasing usage of big data and increasing adoption of internet facilities in healthcare.

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Genomics Market revenue generated by leading players has been determined through primary and secondary research 2019 - 2025.

    The global genomics market is expected to reach US$ 32,995.3 Mn in 2025 from US$ 14,728.6 in 2017. The market is estimated to grow with a CAGR of 10.8% from 2018-2025.

    Genomics market is segmented by technology, product & services, application and end user. Global genomics market, based on technology was segmented into sequencing, microarray, PCR, nucleic acid extraction and purification, and others. Global genomics market, based on the product & services was segmented into instruments/systems, consumables, and services. The genomics market, based on application was segmented into diagnostics, drug discovery & development, precision/personalized medicine, agriculture & animal research and others. The genomics market is bifurcated on basis of end user such research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users.

    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPTE100000730?nb

    The report analyzes factors affecting genomics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key genomics manufacturing companies along with their SWOT analysis and market strategies.

    The objective of the study is to describe, define, and forecast the genomics market by technology, product & services, application, end user and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPTE100000730?nb

    The genomics is defined as the study of a gene and its functioning. The concept of genomics is aimed to understand the architecture of the genome which is comprised of the deoxyribo nucleic acid (DNA), ribo nucleic acid (RNA) and proteins. Genomics is meant to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. The report would be of an interest to various stakeholders operating in the genomics market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

    The top 10 industry players operating in the market of genomics across the globe includes Thermo Fisher Scientific Inc., Illumina Inc., and Eurofins, Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Danaher, and GE Healthcare. For instance, in October 2017, MGI Tech, a subsidiary corporation of BGI, launched two new next generation genetic sequencers, MGISEQ-2000 and MGISEQ-200 in Shenzhen, China. MGI also launched a modular NGS workstation, MGIFLP along with other products. And the launch expanded the business of the company in global genomics market.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Research provides an in-depth analysis of the global Regenerative Medicine Market with the current trends and future estimations to elucidate the imminent investment pockets.

    The "Global Regenerative Medicine Market Analysis to 2025" is a specialized and in-depth study of the regenerative medicine industry with a focus on the global market trend. The report aims to provide an overview of global regenerative medicine market with detailed market segmentation by, product, therapy and application. The global regenerative medicine market is expected to witness substantial growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    Based on product, the market is segmented as, cell based and acellular. The cell based segment is further categorized as, allogeneic and autologous. On the basis of therapy, the market is classified as, gene therapy, cell therapy, tissue engineering, and other therapies. The regenerative medicine market is segmented based on application such as, oncology, orthopedic & musculoskeletal disorders, cardiology, dermatology, and other applications.

    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100001194?nb

    Increase in the global healthcare expenditure coupled with rising prevalence of genetic and chronic diseases is expected to fuel the market growth in the coming years. Considerable rise in the number of individuals opting for organ transplant is expected to provide substantial growth opportunity in the regenerative medicine market during the forecast period.

    Regenerative medicine is an interdisciplinary field of medicine that is used for developing methods to grow, repair or replace diseased or damaged cells, tissues, and organs. Regenerative medicine involves the generation and use of therapeutic stem cells, tissue engineering and the production of artificial organs. Major focus in the regenerative medicine fields are cellular therapies, tissue engineering & biomaterials, and medical devices and artificial organs. Along with replacement of damaged organs, regenerative medicine also helps with the regeneration of the organs.

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global regenerative medicine market based on product, therapy and application. It also provides market size and forecast till 2025 for overall Regenerative Medicine market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA) and South and Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.



    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001194?nb



    North America is expected to hold significant share in the regenerative medicine market, owing to favorable reimbursement and regulatory policies in the United States. The demand for regenerative medicine in Asia Pacific is anticipated to grow at a steady rate during the forecast period, due to increased healthcare expenditure in China and India.

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 29, 2018 ) Research provides an in-depth analysis of the global dPCR and qPCR Market with the current trends and future estimations to elucidate the imminent investment pockets.

    Polymerase chain reaction (PCR) is a technique used to make various copies of deoxyribonucleic acid (DNA) series of interest. This technology is applied in various applications ranging from DNA cloning, functional investigation of genes, paternity testing, detection of contagious diseases, diagnosis of hereditary diseases, and forensic sciences.

    The “Global dPCR and qPCR Market Analysis to 2025” is a specialized and in-depth study of the dPCR and qPCR industry with a focus on the global market trend. The report aims to provide an overview of global dPCR and qPCR market with detailed market segmentation by technology, product, application, and geography. The global dPCR and qPCR market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.



    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100000817?nb



    Increasing number of infectious diseases & genetic disorders and usage of biomarker profiling for disease diagnostics are the major drivers which are likely to propel the growth of dPCR and qPCR market. Plant-derived to genome-based drug discovery is expected to add new opportunities for this market in the coming years.

    The dPCR and qPCR market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

    The dPCR and qPCR market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global dPCR and qPCR market based on technology, product, and application. It also provides market size and forecast till 2025 for overall dPCR and qPCR market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.



    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100000817?nb



    The dPCR and qPCR market report also includes the profiles of key dPCR and qPCR manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Qiagen N.V., Takara Bio, Inc., Agilent Technologies, Inc., Biomérieux S.A., Fluidigm Corporation, Danaher Corporation, ABBott Laboratories, and


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Gene Synthesis Market Analysis and Forecasts to 2025 By Recent Trends, Developments In Manufacturing Technology And Regional Growth Overview.

    The gene synthesis market is aimed to describe, define and estimate the forecast for market size of the gene synthesis till 2025. The report strategically analyzes macro and micro-markets to entail the major factors impacting the growth of the global gene synthesis market. The market report for gene synthesis is appropriate to cater the needs and demands of various stakeholders that include pharmaceutical, research institutes, biotechnology and medical companies in the form of research services.

    The global gene synthesis market estimated to grow at a CAGR of 28.7% during the forecast period from 2018 to 2025. The gene synthesis market was valued at USD 2,866.1 Mn in 2017 and is estimated to reach US$ 20,122.3 Mn by 2025. The global gene synthesis market is segmented on the basis of product & services, application, end user and geography. On the basis of product & services, the gene synthesis market is segmented into consumables, software and services. On the basis of application, the gene synthesis market is segmented into diagnostics, therapeutics, research & developmental activities and others. Based on end user, the gene synthesis market is classified as academic & research institutes, diagnostics laboratories, biotech & pharmaceutical companies and others.

    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100001214?nb



    Gene synthesis is a technique of synthetic biology which is used to create artificial genes in the laboratory. The technique is used for molecular cloning, creating fusion proteins, or achieving sufficiently high protein expression levels. Compared to traditional molecular cloning techniques, the gene synthesis service is helpful in saving both time and money while offering unparalleled top to bottom customizability.

    The products & services segment is expected to accelerate the growth of the global gene synthesis market. Products such as consumables are used in the synthesis of DNA, which includes genetic analysers, DNA synthetizer, and peptide synthetizer. The consumables are used in the numerous stages of the gene synthesis procedures which include sample preparation, storing the samples and its purification, preparation of the library and quantification, and amplification. For instance, Illumina, Inc. offers Nextera DNA Library Prep Kit, ForenSeq DNA Signature Prep Kit, Nextera DNA Flex Library Prep, and Nextera Mate Pair Library Prep Kit for the library preparation in the gene synthesis.



    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001214?nb



    Gene synthesis contribute in not only to improve the understanding of disease mechanisms, but it also provide novel diagnostic tools. The gene synthesis market is segmented into diagnostics, therapeutics, research & developmental activities and others. The methods based on synthetic biology enables in the development of novel strategies for the treatment of cancer, immune diseases metabolic disorders and infectious diseases and the production of cheap drugs. Moreover, the gene synthesis method is widely accepted for the cancer research studies, from initial studies of oncogenic signaling pathways, to the development of DNA vaccines that used in the prevention of cancer or therapeutic antibodies used for immuno-oncology treatments. Thus, the increasing adoption of the gene synthesis in various application is expected to drive the gene synthesis market over the forecast period.

    The major players operating in the gene synthesis market include Thermo Fisher Scientific Inc, Integrated DNA Technologies, Inc., Twist Bioscience, OriGene Technologies, Inc., BioCat GmbH, GenScript, Eurofins Scientific, Bioneer Corporation, ATUM, GENEWIZ and among others. The global gene synthesis market is highly competitive and driven by large number of agreements, collaboration and partnerships. For instance, in July 2017 Twist Bioscience signed an agreement with Synbio Technologies. The aim of the agreement is to provide the next generation DNA manufacturing and long-length DNA assembly at a commercial scale to customers across the globe.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Research provides an in-depth analysis of the global Healthcare Quality Management Market with the current trends and future estimations to elucidate the imminent investment pockets.

    Increase in the quantity of unorganized data in the healthcare industry and need to reduce the healthcare costs are anticipated to fuel the market growth during the coming years. Rise in the ageing population across the globe along with increasing focus towards patient satisfaction is considered to provide growth opportunity in the market during the forecast period.

    The Healthcare Quality Management market is segmented based on software as, clinical risk management solutions, business intelligence and analytics solutions, physician quality reporting solutions, and other software. On the basis of delivery mode, the market is classified as, web & cloud based and on premise. The market is segmented based on application as, Risk Management and Data Management. On the basis of end user, the market is categorized as, hospitals, ambulatory centers, payers, and other end users.

    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100001216/?nb

    Quality management is an essential aspect in healthcare organizations and patients. One of the primary reason for the implementation of high management quality control in the healthcare industry is to ensure that proper care facilities are being offered to the patients. This function is being adopted by hospitals and medical clinics in order to show diligence to take optimal care of their patients. With the help of quality management, effectiveness of treatment can be improved along with better patient satisfaction.

    The "Global Healthcare Quality Management Market Analysis to 2025" is a specialized and in-depth study of the healthcare quality management industry with a focus on the global market trend. The report aims to provide an overview of global healthcare quality management market with detailed market segmentation by software, delivery mode, application, end user and geography. The global healthcare quality management market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global healthcare quality management market based on software, delivery mode, application, and end user. It also provides market size and forecast till 2025 for overall healthcare quality management market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.



    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001216/?nb



    North America is expected to hold significant share during the coming years, owing to the rise in the ageing population and the need to improve population health management in the United States. The region of Asia Pacific is anticipated to witness growth at a significant rate, due to the increase in the adoption of digital techniques in the healthcare industry.

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 29, 2018 ) According to the new market research report "Cholesterol Screening/ Cholesterol Lab Testing Services Market by Type of Customer (Physician/Provider, Hospital, Employer, Health Plan, MCO, Government, ACO, IDN, Patient), Geography (North America, Europe) & Qualitative Assessment - Forecasts to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    Don’t miss out on business opportunities in Cholesterol Screening/ Cholesterol Lab Testing Services Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=180941049

    Factors such as increasing incidence of cardiovascular diseases and obesity, physician preference of laboratory testing rather self-testing, growing awareness and adoption of preventive healthcare, government initiatives to improve the quality of testing, and rapid growth in the geriatric population are propelling the growth of this market. Moreover, emerging economies offer significant growth opportunities for players operating in the cholesterol testing services market. On the other hand, rapidly growing home/self-testing and emergence of non-invasive cholesterol testing methods are the major factors that may limit growth of the market to a certain extent.

    The cholesterol testing services market is segmented based on type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients. The patient-driven cholesterol testing segment is expected to grow at the highest CAGR during the forecast period, mainly due to increasing awareness and adoption of preventive healthcare, availability of lab test services for patients without any physician intervention thus reducing the waiting time to get appointment from physicians, and online access to reports and readings through smartphones.

    Browse and in-depth TOC on " Cholesterol Testing Services Market "
    33 – Tables
    21 - Figures
    139 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/cholesterol-testing-services-market-180941049.html

    The report categorizes the cholesterol testing market on the basis of type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies,
    Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients. In 2016, the physicians/providers and hospitals segment is projected to account for the largest share of the market. The large share of this segment can be attributed to factors such as dependence of physicians on cholesterol test results for making CVD risk assessments and treatment decisions and reimbursement of tests that are prescribed by physicians/doctors.

    Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=180941049

    The cholesterol testing market is segmented on the basis type of customer and region. Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients. Companies in the market are coming up with innovative offerings to provide accurate and up-to-date diagnostic information to their customers. In November 2016, Quest Diagnostics (U.S.) launched the QuestDirect, a new patient-initiated testing service, in the U.S. This new service will allow the customers better manage their health by ordering certain lab tests directly without any physician intervention.

    Based on region, the cholesterol testing services market is segmented into
    North America, Europe, Asia, and RoW. North America is expected to dominate the global cholesterol testing market in 2016, with the U.S. accounting for a major share. Asia is projected to be the fastest-growing region in terms of CAGR during the forecast period. This is due to the large population base, increased prevalence of cardiovascular diseases, and growing number of testing facilities in the Asian region.

    Key Players:
    Major players in the cholesterol testing market include Laboratory Corporation of America Holdings (LabCorp) (U.S.), Quest Diagnostics Incorporated (U.S.), Eurofins Scientific (Luxembourg), Spectra Laboratories Inc. (U.S.), Unilabs (Switzerland), SYNLAB International GmbH (Germany), Bio-Reference Laboratories Inc. (U.S.), Clinical Reference Laboratory, Inc. (CRL) (U.S.), ACM Medical Laboratory (U.S.), and Adicon Clinical Laboratory (China).

    Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, November 29, 2018 ) Global eHealth Market In-Depth Profiling With Key Players and Recent Developments, Forecast Period: 2019-2025

    The “Global eHealth Market Analysis to 2025” is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global eHealth market with detailed market segmentation by product & services, end user and geography. The global eHealth market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    The growth of the market can be attributed to increasing government initiatives supporting the use of eHealth solutions & services to deliver the higher care at low costs. Moreover, high prevalence of chronic diseases and growing need to manage regulatory compliance through the use of eHealth solutions are the factors that add new opportunities for the global eHealth market over the forecast period.

    The eHealth is used as an information and communication technology (ICT) for the development of healthcare infrastructure. These systems enables the healthcare facilities to offer personalized medicine, mobile health delivery, and social media e-health to their patients. Based on innovative technology these eHealth systems prioritize the delivery of clinical information, care & services.



    Get sample PDF copy @ https://www.theinsightpartners.com/sample/TIPHE100001210?nb



    On the basis of product & services the market is segmented into eHealth solutions and eHealth services:

    The eHealth solutions segment is further segmented as cardiovascular information systems, e-prescribing solutions, radiology information systems, healthcare information exchange, telehealth solutions, clinical decision support systems, chronic care management apps, personal health record & patient portals, laboratory information systems, laboratory information systems, medical apps, pharmacy information systems, PACS & VNAS, electronic health records/electronic medical records solutions and other specialty information management systems. The eHealth services market is also further segmented into healthcare system strengthening services, treatment services, diagnosis & consultation services and remote monitoring services. Based on end user the eHealth market classified as healthcare providers, healthcare payers, and other end users.

    The report provides a detailed overview on the industry including both qualitative and quantitative information

    It provides overview and forecast of the global eHealth based on product & service and end user. It also provides market size and forecast till 2025 for overall eHealth market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.



    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001210



    North America followed by Europe, is expected to dominate the eHealth market in the global arena due to the well-established healthcare infrastructure, and rising number of initiatives from the American Health Information Community (AHIC) in the region. Asia-Pacific region is anticipated to show a significant growth rate over the next five years in the global eHealth market due to the increasing usage of big data and increasing adoption of internet facilities in healthcare.

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 29, 2018 ) According to the new market research "Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021" published by MarketsandMarkets

    Don’t miss out on business opportunities in Lung Cancer Surgery Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=222

    The objectives of this study are as follows:

    • To define, describe, and forecast the global lung cancer surgery market by device, surgery, and region
    • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product launches, agreements, expansions, acquisitions, and other developments in the global lung cancer surgery market

    Browse and in-depth TOC on “Lung Cancer Surgery Market "
    85 – Tables
    44 – Figures
    135 – Page
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/lung-cancer-market-222.html

    Based on procedure, the market is segmented into thoracotomy and minimally invasive surgeries. The thoracotomy segment further sub segmented into lobectomy, segmentectomy, sleeve resection, and pneumonectomy. The minimally invasive surgeries segment is expected to grow at the highest CAGR during the forecast period due to increasing awareness about early detection of lung cancer and advantages of MIS over conventional surgeries.

    Based on region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. Growth in this market is mainly driven by the increasing geriatric population, availability of reimbursement for lung cancer surgeries, increasing number of lung cancer awareness programs, and technological advancements in cancer treatment.

    Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=222

    Market Players
    Key players in the lung cancer surgery market include Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).

    Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 29, 2018 ) The global digital forensics market is estimated to grow at a CAGR of 10.9% during the forecast period 2018 – 2025 and accounts for US$ 6.95 Bn in the year 2025.

    As new technologies evolve, lawbreakers find distinct methods to use these technologies to obligate crimes. With the explosion of web technologies almost all major businesses in the world have web presence thus exposing their data to legitimate and illegitimate users. Computers, mobile devices and clouds and IoT have become intrinsic part of our lives. Businesses have streamlined their operation saving millions of dollars because of the web technologies and services. Because of such intricate involvement of technology in all aspects of our lives, it also has become legal evidence in both civil and criminal cases. Digital evidences admitted in courts could be any file or fragment recovered from the storage devices such as email, browsing history, graphics, photographs, or application documents. These files may be undeleted or deleted.

    Sample Copy of this Report is Available at @ http://bit.ly/2AjjPf3

    The Digital forensics market segmentation is done on the basis of type, component, and end-user. The type segment of digital forensics market includes end-point forensics, network forensics, cloud forensics and mobile devices. Also, the digital forensics market has been bifurcated on the basis of component into software and services. Lastly, these various software and hardware tools for digital forensics are used across a large number of industry verticals. Thus, the end-user segment also forms the basis of market segmentation in the study. Consecutively, the market for digital forensics on the basis of end-users is segmented into Government, BFSI, Healthcare, Retail, Manufacturing and Communication & Media Services. On the basis of geography, the Digital forensics market is analyzed into North America, Europe, Asia- Pacific (APAC), Middle East & Africa (MEA) and South America (SAM).

    Top Companies profiled in this report:

    1. Forensicon
    2. R3 Digital Forensics
    3. FireEye, Inc.
    4. ACCESS DATA
    5. Cy4or Legal Limited
    6. Binary Intelligence, LLC
    7. Kroll
    8. LogRythm, Inc.
    9. Magnet Forensics
    10. Global Digital Forensics Inc.

    Europe comprises of highly developed economies and is affecting positively for the machine learning market, as businesses are open to adopting new emerging technologies. This enables them to spend more on the attainment of skilled labors and efficient business processes. Also, as purchasing power of individuals is quite high the competition to provide them with the best product is also very high, which forces the industries to implement effective intelligent strategies. The population growth of Europe is very slow as compared to the other regions in the world. The region has higher death than birth rates, and registers lowest birth ratio in the world. This is due to lower-fertility rates as there are fewer women of child bearing age. Also, the labor available is expensive, which could be a big challenge for Europe in the future. Europe’s population is continuously decreasing for instance, it is anticipated that Italy will lose 28 percent of its population by 2050. This will result in decreasing working age population in the region and further increase the demand for labor outsourcing.

    Get Reasonable Discount on this Report @: http://bit.ly/2yrbtkp

    Digital forensics market is expected to experience significant growth in the coming years due to the increasing demand focus on privacy, security and growing use of smart devices which include intelligent transport system, smart city and smart healthcare, exhibiting substantial market growth. Digital forensics is has set the highest growth record in North America in 2016. Whereas, APAC is expected to grow at a fast pace and therefore have highest growth rate during the forecast period. BFSI industry is the largest application segment among other digital forensics application however, the growth of digital forensics in government applications including is rising digital forensics market in coming years.

    Reason to Buy:
    - Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Digital forensics Market
    - Highlights key business priorities in order to assist companies to realign their business strategies.
    - The key findings and recommendations highlight crucial progressive industry trends in the Digital forensics Market, thereby allowing players to develop effective long term strategies.
    - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 30, 2018 ) According to the new market research report "Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021" published by MarketsandMarkets™, the global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period.

    Don’t miss out on business opportunities in Nasal Drug Delivery Technology Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=192818058

    Increasing patient preference for nasal drug delivery because of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the nasal drug delivery technology market. Furthermore, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offers significant growth opportunities for player operating in the market. On the other hand, complications associated with the overuse of nasal sprays may restraint the growth of the market.

    The nasal drug delivery technology market is segmented based on dosage form, therapeutic application, end user, system, container, and region. Based on therapeutic application, the market is segmented into allergic and non-allergic rhinitis, nasal congestion, vaccination, and other therapeutic applications (osteoporosis, pain management, and sexual dysfunction). The allergic and non-allergic rhinitis segment is expected to register the highest CAGR during the forecast period. The high growth in this segment can primarily be attributed to the increasing prevalence of allergic and non-allergic rhinitis and growing preference for nasal drugs for its treatment.

    Browse and in-depth TOC on “Nasal Drug Delivery Technology Market "
    95 – Tables
    36 – Figures
    212 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/nasal-drug-delivery-technology-market-192818058.html

    Based on region, the nasal drug delivery technology market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is further subsegmented into the U.S. and Canada; while Europe is further subsegmented into Germany, France, the U.K., and Rest of Europe (RoE); Asia is further subsegmented into Japan, China, India, and Rest of Asia (RoA). In 2016, North America is expected to dominate the market, followed by Europe. This growth can be attributed to the increasing prevalence of COPD, rising adoption of nasal drug delivery technology, and the significant presence of major market players in the U.S.

    Asia is projected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.

    Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=192818058

    Key Players:
    The nasal drug delivery technology market is at a very nascent stage with various players. Prominent players in this market include Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), AstraZeneca plc. (U.S.), AptarGroup (U.S.), and GlaxoSmithKline plc (U.K.).

    Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, November 30, 2018 ) According to the new market research report "Pulmonary/ Respiratory Drug Delivery Market by Formulation (Type (Solution, Suspension, Dry powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications (COPD) - Forecasts to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities.

    Don’t miss out on business opportunities in Pulmonary/ Respiratory Drug Delivery Market.
    Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=179682410

    The global pulmonary drug delivery market is projected to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in 2016, at a CAGR of 6.5% during the forecast period. Growth in this market is mainly driven by increasing preference of pulmonary route of drug delivery, increasing technological developments in the form of smart/digital inhalers and rising incidences of respiratory diseases such as COPD, asthma, and cystic fibrosis.

    The respiratory drug delivery market by formulation segment is further divided into device type and formulation type. The market, by device type, is categorized into metered dose inhalers, dry powder inhalers, and nebulizers. The dry powder inhalers segment is expected to witness the highest growth during the forecast period due to the advantages associated with the use of these inhalers, such as short administration & preparation time, ease of use, and fewer irritant effects.
    The pulmonary drug delivery market, based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles.

    Browse and in-depth TOC on "Pulmonary/ Respiratory Drug Delivery Market"
    104 – Tables
    33 - Figures
    150 - Pages
    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pulmonary-respiratory-drug-delivery-market-179682410.html

    The pulmonary drug delivery market, based on formulation type, is segmented into suspension aerosol, solution aerosol, and dry powder formulation. The dry powder formulation segment is expected to witness the highest growth during the forecast period due to improved dosage accuracy, minimized dosage variability, and improved flow of drug particles.

    Based on applications, the market is segmented into asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and other applications (cardiovascular disease, diabetes, respiratory therapy, and treatment of patients on ventilators). The asthma segment accounts for the major share in the market during the forecast period due to increasing prevalence of asthma across the globe.

    Request for Free Sample Report @
    https://www.marketsandmarkets.com/requestsample.asp?id=179682410

    Currently, North America dominates the pulmonary drug delivery devices market, and Asia represents the second-largest regional market. Moreover, the Asian market is expected to register the highest CAGR during the forecast period due to the rapidly growing geriatric population, growing adoption of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals, and the subsequent increase in the prevalence of COPD in the region.

    Key Players
    Prominent players in the pulmonary drug delivery market include GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

    Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

older | 1 | .... | 1101 | 1102 | (Page 1103) | 1104 | 1105 | .... | 1118 | newer